Clinical Trials Update: July 11, 2007
Epilepsy Healthy Patient Studies Pancreatic Cancer
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will assess the safety and effectiveness of responsive brain stimulation in reducing the frequency of medically uncontrolled partial onset seizures. To participate, you must be 18-70 years old, and have no more than two epileptogenic brain regions.
The research site is in San Francisco, Calif.
Healthy Patient Studies
You may qualify for this study if you are generally healthy, ages 18 to 55, tobacco and nicotine free, and willing to stay for nine consecutive overnights at the study clinic. Participants receive up to $2,300 compensation upon study completion.
The research site is in Evansville, Ind.
This study will evaluate the effects on pancreatic cancer patients of gemcitabine alone, versus a combination of drugs followed by the addition of gemcitabine at the time of the cancer's first progression. Participants must be 18-75, with healthy livers, and cannot be pregnant, have had radiotherapy within the past eight weeks, or be HIV positive.
The research site is in Boca Raton, Fla.
Copyright 2007 Thomson CenterWatch. All rights reserved.